Cochlear Implant With Dexamethasone Eluting Electrode Array
Cochlear Implant With Dexamethasone Eluting Electrode Array (The CI-DEX Study): Pivotal Study
Sponsor: Avania
A NA clinical study on Bilateral Hearing Loss and Sensorineural Hearing Loss, this trial is completed. The trial is conducted by Avania and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
May 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Oct 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jun 2022 — Nov 2022 [monthly]
Recruiting NA
-
Apr 2022 — Jun 2022 [monthly]
Recruiting NA
-
Oct 2021 — Apr 2022 [monthly]
Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Avania
- Cochlear
- NAMSA
- Vanderbilt University
For direct contact, visit the study record on ClinicalTrials.gov .